BridgeBio amends 2021 stock option and incentive plan
BridgeBio Pharma filed a Third Amended and Restated 2021 Stock Option and Incentive Plan. The update aims to expand equity compensation opportunities to align key personnel interests with shareholder value.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day